TheEdgeResearch
Home / Stocks / MXCT

MaxCyte, Inc. (MXCT)

NASDAQ Healthcare Biotechnology
$1.37 ▲ +7.03%
Market Cap
$141.5M
Sector
Healthcare
Industry
Biotechnology
Beta
1.48
52-Wk Range
0.643-1.8
CEO
Maher Masoud
Country
US
Currency
USD

MaxCyte, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Rockville, MD, US. The stock last traded at $1.37, up 7.03% on the session, giving a market capitalisation of $141.5M. On trailing twelve-month figures it carries a trailing P/E of -5.18, a net margin of -81.4%. Its beta of 1.48 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-5.18
Price / Sales
4.12
Price / Book
0.94
EV / EBITDA
-6.15
Gross margin
78.0%
Operating margin
-87.7%
Net margin
-81.4%
Return on equity
—
Debt / equity
0.11
Current ratio
7.83
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
91
IPO date
2021-07-29
Headquarters
Rockville, MD, US
About MaxCyte, Inc.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Comparable companies

MaxCyte, Inc. is most often compared with the following Healthcare names:

ARMPAVRCATXLNSRNNOXOWLTPREPROFSGMOTLSI
More research on MXCT
MXCT technical analysis MXCT TheEdge Score Compare against peers
Open full interactive analysis & DCF →